FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years
Clinical trial NCT00254410 · COMPLETED
Trial details
- NCT number
- NCT00254410
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-14
- Primary completion
- 2017-09-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.